Taizhou Dexiang Medical Chemical Co., Ltd. is an enterprise specializing in the production of pharmaceutical intermediates and chemical products. The nature of the enterprise is a limited liability joint stock company. Founded in June 2006, the company covers an area of 46278m2 and a planned construction area of 30657m2. It is located in the coastal park of Zhejiang chemical API base, a chemical API base. It has more than 221 employees, including more than 130 professional and technical personnel. The predecessor of the company has more than ten years of pharmaceutical and chemical production experience. It was founded as early as 1992. With years of technology and capital accumulation and the momentum of continuous development, the company has now developed into a professional manufacturer of pharmaceutical and chemical products with advanced technical force, equipment and facilities. The company's main products include stavudine, bicalutamide, pyrroletanib, metformin hydrochloride, d-amide, bah, BBA, 2-aminopyridine, 3-hydroxyacetophenone and other APIs and intermediates. There are dozens of product varieties, with an annual output of more than 100 tons of various pharmaceutical and chemical intermediates. Products can be customized or developed according to customer needs, or various forms of project cooperation.